Insulet Corporation

Insulet Corporation, a medical device company, develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The Company offers Omnipod Insulin Management System (Omnipod System), which consists of the OmniPod, an easy-to-use continuous insulin delivery system and Personal Diabetes Manager, a handheld wireless device. It also customizes the Omnipod System technology platform for the delivery of subcutaneous drugs across various therapeutic areas. Insulet Corporation sells and markets its Omnipod System through a combination of direct sales representatives and independent distributors.

Company Growth (employees)
Type
Public
HQ
Billerica, US
Founded
2000
Size (employees)
640 (est)
Insulet Corporation was founded in 2000 and is headquartered in Billerica, US

Key People/Management at Insulet Corporation

Patrick Sullivan

Patrick Sullivan

Chairman of the Board and Chief Executive Officer
Aiman Abdel-Malek

Aiman Abdel-Malek

Senior Vice President, Advanced Technology and Engineering
Bret Christensen

Bret Christensen

Senior Vice President and Chief Commercial Officer
David Colleran

David Colleran

Senior Vice President, Secretary and General Counsel
Deborah Gordon

Deborah Gordon

Vice President, Investor Relations and Corporate Communications
Michael Levitz

Michael Levitz

Senior Vice President, Chief Financial Officer and Treasurer
Trang Ly

Trang Ly

Vice President and Medical Director
Shacey Petrovic

Shacey Petrovic

President and Chief Operating Officer
Michael Spears

Michael Spears

Senior Vice President, Quality and Regulatory Affairs
Brad Thomas

Brad Thomas

Executive Vice President, Human Resources and Organizational Development

Insulet Corporation Office Locations

Insulet Corporation has offices in Billerica, Denver, Tulsa, Washington and in 11 other locations
Billerica, US (HQ)
200 600 Technology Park Dr
Show all (15)

Insulet Corporation Financials and Metrics

Insulet Corporation Financials

Insulet Corporation's revenue was reported to be $367 m in FY, 2016
USD

Revenue (Q2, 2017)

109.8 m

Gross profit (Q2, 2017)

64.6 m

Gross profit margin (Q2, 2017), %

59%

Net income (Q2, 2017)

(7.8 m)

EBIT (Q2, 2017)

(3.4 m)

Market capitalization (16-Feb-2018)

4.5 b

Cash (30-Jun-2017)

73.5 m
Insulet Corporation's current market capitalization is $4.5 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

247.1 m288.7 m324.2 m367 m

Revenue growth, %

17%12%13%

Cost of goods sold

134.7 m145.4 m176.1 m155.9 m

Gross profit

112.4 m143.3 m148.2 m211.1 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Revenue

61.1 m69.2 m72 m75 m61.2 m75.6 m87.3 m81.2 m87.3 m94.9 m101.7 m109.8 m

Cost of goods sold

33.7 m36.4 m36.2 m36.9 m28.4 m41.2 m51.7 m37.2 m36.9 m39.2 m42.3 m45.1 m

Gross profit

27.4 m32.8 m35.8 m38 m32.8 m34.4 m35.7 m44.1 m50.5 m55.6 m59.4 m64.6 m

Gross profit Margin, %

45%47%50%51%54%45%41%54%58%59%58%59%
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

149.7 m151.2 m122.7 m137.2 m

Accounts Receivable

33.1 m39.9 m48.4 m28.8 m

Inventories

9.5 m13.1 m5.7 m35.5 m

Current Assets

198.2 m208.2 m190.8 m370 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Cash

153.9 m145.6 m175.5 m146.4 m145.6 m145.1 m145.5 m111.6 m75.7 m215.4 m76 m73.5 m

Accounts Receivable

34.5 m36.7 m41.8 m47.1 m36.1 m31.8 m31.8 m40.5 m38.7 m38.5 m40.6 m37.8 m

Inventories

5.4 m10.4 m8.8 m9.7 m20.1 m23.4 m13 m14 m24.5 m32.7 m34.3 m34 m

Current Assets

199.7 m199.9 m231.8 m206.6 m205.4 m203.8 m194.3 m171.8 m181.3 m361.8 m337.2 m338.7 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(45 m)(51.5 m)(73.5 m)(28.9 m)

Depreciation and Amortization

11.8 m12.2 m15.8 m13.8 m

Accounts Receivable

(4.5 m)(10 m)(9.8 m)12.6 m

Inventories

5.4 m(3.6 m)(722 k)(24.1 m)
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Net Income

(42.5 m)(6.1 m)(35.3 m)(46.1 m)(11.8 m)(27.3 m)(46.2 m)(12.5 m)(16.7 m)(19.8 m)(10 m)(17.7 m)

Depreciation and Amortization

8.9 m3.1 m6.1 m9.2 m3.4 m7.1 m11.4 m3.4 m6.8 m10.5 m3.3 m6.7 m

Accounts Receivable

(5.1 m)(4.5 m)(10.5 m)(16.7 m)3.5 m6.9 m5.3 m2.3 m3.7 m3 m(12.1 m)(9.6 m)

Inventories

9.5 m(985 k)699 k(198 k)(7 m)(10.3 m)312 k(2.6 m)(13.1 m)(21.3 m)1.2 m1.5 m
Y, 2017

Financial Leverage

7.1 x
Show all financial metrics

Insulet Corporation Operating Metrics

FY, 2016

Patents Issued

23

Patents Pending

32
Show all operating metrics

Insulet Corporation Market Value History

Insulet Corporation Revenue Breakdown

Insulet Corporation's Web-traffic and Trends

Insulet Corporation Online and Social Media Presence

Insulet Corporation Company Life and Culture

You may also be interested in